Subscribe
Subscribe today to receive CGD’s latest newsletters and topic updates.
All Commentary
Filters:
Topics
Facet Toggle
Content Type
Facet Toggle
Blog Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
April 08, 2024
When Gavi, the Vaccine Alliance, was founded in 2001, it logically targeted its support to the poorest countries—with GNI per capita under a pre-defined eligibility threshold—that also had the highest shares of the world’s undervaccinated children. Fast-forward almost 25 years, and the situation has...
Blog Post
June 13, 2023
This Thursday, the Center for Global Development is hosting a half-day event—Get the Lead Out—to shine a much-needed spotlight on the far-reaching social and economic consequences of lead poisoning. Lead is an insidious toxin. In most cases, it has no overt, easily detectable symptoms when ingested—...
Blog Post
February 06, 2023
Today, we publicly launch an independent assessment which offers an overview of the global lead poisoning crisis; takes stock of current initiatives within G7 partners and international organisations to reduce lead poisoning globally; and identifies promising opportunities to make a difference. Here...
Blog Post
December 08, 2022
The world desperately needs new antibiotics—and finally, the G7 is ready match commitments with action. We already found that the US would pay $17.9 billion over 30 years but save 383,000 American lives and harvest $495 billion in value. What would be the benefits to other members of the G7, and who...
Blog Post
November 28, 2022
Building on the success of Operation Warp Speed, the US should deepen its engagement and ambition in global health R&D to drive transformative improvements in global health outcomes and security. Specifically, it should consider a subscription model for new antimicrobials; an advance market commitme...
Blog Post
November 15, 2022
Congress has excellent legislation on the docket that would protect American citizens, yield huge returns, and create a safer, healthier world. We encourage the US Congress to urgently finance and authorize the PASTEUR Act, leveraging American ingenuity to boost our shared health future.
Blog Post
October 04, 2022
Most R&D money flows from the private sector, which aims to maximize returns on investment. As a result, health R&D largely skews towards rich countries’ priorities and health system technical capacities, leaving significant gaps in diseases that primarily affect poor and marginalized populations.